AMINO ACIDS, BRANCHED-CHAIN
Concussion
Akiva CohenmixturePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Concussion cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Prometrium Wake Forest University Health Sciences | Phase 4 | BB |
TROFINETIDE Neuren Pharmaceuticals Limited | Phase 2 | CCC |
LIDOCAINE University of Michigan | Phase 2 | CCC |
Docosahexaenoic Acid University of Texas Southwestern Medical Center | Phase 1 | CC |
BLOOD, WHOLE Children's Hospital Medical Center, Cincinnati | N/A | D |
Same molecule, other indications
AMINO ACIDS, BRANCHED-CHAIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →